SCHEMBL31269255

SCHEMBL31269255

COc1ccc(Cn2c(-c3ccc(CC(N)=O)cc3Cl)nc3c(OC4(C)CC4)ncnc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.38
▸ CNR1 P21554 2/20 0.38
▸ PIK3CD O00329 2/20 0.36
▸ PLA2G2A P14555 5/20 0.35
▸ DGAT1 O75907 1/20 0.35
▸ PDE1B Q01064 2/20 0.34
▸ PDE1A P54750 1/20 0.34
▸ PDE1C Q14123 1/20 0.34
▸ SCD O00767 1/20 0.34
▸ DCTPP1 Q9H773 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ CASP7 P55210 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269283 0.94 PIK3CD (0.38) PDE10ACNR1PIK3CDDGAT1KDM4E
SCHEMBL31268757 0.93 PLA2G2A (0.38) PLA2G2AALDH1A1HSD17B10USP2MAPK1
SCHEMBL31269290 0.92 PIK3CD (0.37) PDE10ACNR1PIK3CDPLA2G2ADGAT1
SCHEMBL31269240 0.92 PDE8A (0.35) PDE10ACNR1PIK3CDPLA2G2ADGAT1
SCHEMBL31268788 0.91 PIK3CD (0.37) CNR1PIK3CDDGAT1USP2LMNA
SCHEMBL31269316 0.90 PIK3CD (0.35) PDE10ACNR1PIK3CDPLA2G2ADGAT1
SCHEMBL31269133 0.89 PLA2G2A (0.38) PDE10ACNR1PIK3CDPLA2G2ADGAT1
SCHEMBL31268878 0.89 PIK3CD (0.36) PDE10ACNR1PIK3CDPLA2G2ADGAT1
SCHEMBL31269049 0.89 GPR119 (0.37) CNR1PIK3CDDGAT1DCTPP1PTGDR2
SCHEMBL31268991 0.89 PIK3CD (0.36) PDE10ACNR1PIK3CDDGAT1PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback